These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16515285)

  • 1. [Ergenyl chronospheres in bipolar disorders].
    Grunze H
    Krankenpfl J; 2005; 43(7-10):213. PubMed ID: 16515285
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ergenyl chronospheres in juvenile and senile epilepsies].
    Krämer G
    Krankenpfl J; 2005; 43(7-10):213. PubMed ID: 16515286
    [No Abstract]   [Full Text] [Related]  

  • 3. Pediatric bipolar disorder: evidence-based psychopharmacological treatments.
    Banuelos-Arzac C
    J Child Adolesc Psychiatr Nurs; 2008 May; 21(2):68. PubMed ID: 18429835
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and tolerability of divalproex extended release in psychiatric patients.
    Jackson RS; Venkataraman S; Atkins RB; Owens M
    Ann Clin Psychiatry; 2006; 18(4):273-4. PubMed ID: 17162629
    [No Abstract]   [Full Text] [Related]  

  • 5. Extended-release divalproex sodium for patients with side effects from delayed-release divalproex sodium.
    Longo LP
    Am J Psychiatry; 2005 Aug; 162(8):1548-9. PubMed ID: 16055790
    [No Abstract]   [Full Text] [Related]  

  • 6. Antidepressant action of atypical antipsychotics: focus on ziprasidone monotherapy, with a few twists in the tale.
    Andrade C
    J Clin Psychiatry; 2013 Mar; 74(3):e193-6. PubMed ID: 23561239
    [No Abstract]   [Full Text] [Related]  

  • 7. Valproate: do formulations matter?
    Citrome L
    J Clin Pharm Ther; 2008 Aug; 33(4):457; author reply 458. PubMed ID: 18613865
    [No Abstract]   [Full Text] [Related]  

  • 8. Dose-dependent valproic acid thrombocytopenia in bipolar disorder.
    Kaufman KR; Gerner R
    Ann Clin Psychiatry; 1998 Mar; 10(1):35-7. PubMed ID: 9622048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful reintroduction of valproic acid after the occurrence of pancytopenia.
    Stewart JT
    Am J Geriatr Pharmacother; 2011 Oct; 9(5):351-3. PubMed ID: 21962938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproate-induced encephalopathy related to concurrent antimanic medications.
    Trojak B; de la Gastine B; Dollfus S
    J Neuropsychiatry Clin Neurosci; 2011; 23(1):E22-3. PubMed ID: 21304120
    [No Abstract]   [Full Text] [Related]  

  • 11. Pancytopenia and valproic acid: a dose-related association.
    Oluboka OJ; Haslam D; Gardner DM
    J Am Geriatr Soc; 2000 Mar; 48(3):349-50. PubMed ID: 10733073
    [No Abstract]   [Full Text] [Related]  

  • 12. Spectrum of effectiveness of valproate in neuropsychiatry.
    Bowden CL
    Expert Rev Neurother; 2007 Jan; 7(1):9-16. PubMed ID: 17187491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deconstructing a medication regimen.
    Preskorn SH
    J Psychiatr Pract; 2008 Mar; 14(2):114-8. PubMed ID: 18360197
    [No Abstract]   [Full Text] [Related]  

  • 14. Dosing of divalproex extended release.
    Feifel D
    J Clin Psychiatry; 2007 Jul; 68(7):1146-7; author reply 1147. PubMed ID: 17685756
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravenous valproate treatment: some observations.
    Duggal HS
    Can J Psychiatry; 2002 Feb; 47(1):96. PubMed ID: 11873717
    [No Abstract]   [Full Text] [Related]  

  • 16. Adjunctive treatment of acute mania: a clinical overview.
    Sachs GS; Gardner-Schuster EE
    Acta Psychiatr Scand Suppl; 2007; (434):27-34. PubMed ID: 17688460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ammonia induced encephalopathy from valproic acid in a bipolar patient: case report.
    Elgudin L; Hall Y; Schubert D
    Int J Psychiatry Med; 2003; 33(1):91-6. PubMed ID: 12906346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatotoxicity with combination of valproic acid, ritonavir, and nevirapine: a case report.
    Cozza KL; Swanton EJ; Humphreys CW
    Psychosomatics; 2000; 41(5):452-3. PubMed ID: 11015639
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential risks associated with high-dose valproate in pregnancy in psychiatric patients.
    Vajda FJ; Solinas C
    Aust N Z J Psychiatry; 2005 Jun; 39(6):526-7. PubMed ID: 15943661
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inappropriate antidiuretic hormone secretion induced by sodium valproate].
    Bève E; Beck E; Pinto E; Ansseau M
    Rev Med Liege; 2010 Jan; 65(1):6-9. PubMed ID: 20222501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.